* SeaStar Medical Holding Corp ICU.OQ ICU.O is expected
to report resultson March 29 (estimated) for the period ending
December 31 2023
*
* LSEG's mean analyst estimate for SeaStar Medical Holding
Corp
is for a loss of 13 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for SeaStar
Medical
Holding Corp is $2.00, above its last closing price of $0.74.
This summary was machine generated March 27 at 11:43 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)